COX-2 expression does not correlate with microvessel density in breast cancer

Mangesh A. Thorat, Sanjana Mehrotra, Akira Morimiya, Sunil Badve

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Cyclooxygenase-2 (COX-2), implicated in carcinogenesis and tumour progression in many cancers including breast cancer, is hypothesised to cause progression by promoting angiogenesis. The exact mechanism of such action is not known and the clinical evidence of such interaction is weak. We studied COX-2 expression and microvessel density (MVD) in malignant breast tissues. Methods: COX-2 expression was analysed by immunohistochemistry in 89 breast cancer cases. MVD was assessed by CD31 immunohistochemistry using the Chalkey count method. COX-2 expression and MVD data were correlated with each other and with other prognostic factors. Results: COX-2 expression, observed in 70 (79%) cases, correlated positively with tumour type (p = 0.037) and tumour grade (p = 0.045), but negatively with oestrogen receptor (p = 0.013). It did not correlate with tumour size, axillary lymph node status, progesterone receptor and HER-2 status. MVD varied from 2.09 to 40.38, correlated positively with tumour grade (p = 0.050) and tumour size (p = 0.044), but negatively with progesterone receptor (p = 0.040). MVD did not correlate with tumour type, axillary lymph node status, oestrogen receptor and HER-2. There was no correlation between COX-2 expression and MVD (p = 0.702). Conclusions: COX-2 expression does not correlate with angiogenesis in breast cancer. Angiogenesis in breast cancer may be dependent on multiple genes, rather than on COX-2 alone.

Original languageEnglish (US)
Pages (from-to)39-44
Number of pages6
JournalPathobiology
Volume76
Issue number1
DOIs
StatePublished - Feb 1 2009

Fingerprint

Cyclooxygenase 2
Microvessels
Breast Neoplasms
Neoplasms
Progesterone Receptors
Lymph Nodes
Immunohistochemistry
Estrogen Receptor beta
Estrogen Receptors
Carcinogenesis
Breast
Genes

Keywords

  • Angiogenesis
  • Breast cancer
  • Cyclooxygenase
  • Immunohistochemistry
  • Microvessel density

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

COX-2 expression does not correlate with microvessel density in breast cancer. / Thorat, Mangesh A.; Mehrotra, Sanjana; Morimiya, Akira; Badve, Sunil.

In: Pathobiology, Vol. 76, No. 1, 01.02.2009, p. 39-44.

Research output: Contribution to journalArticle

Thorat, Mangesh A. ; Mehrotra, Sanjana ; Morimiya, Akira ; Badve, Sunil. / COX-2 expression does not correlate with microvessel density in breast cancer. In: Pathobiology. 2009 ; Vol. 76, No. 1. pp. 39-44.
@article{91d5c513adcd4ae3b71832b31177862d,
title = "COX-2 expression does not correlate with microvessel density in breast cancer",
abstract = "Background: Cyclooxygenase-2 (COX-2), implicated in carcinogenesis and tumour progression in many cancers including breast cancer, is hypothesised to cause progression by promoting angiogenesis. The exact mechanism of such action is not known and the clinical evidence of such interaction is weak. We studied COX-2 expression and microvessel density (MVD) in malignant breast tissues. Methods: COX-2 expression was analysed by immunohistochemistry in 89 breast cancer cases. MVD was assessed by CD31 immunohistochemistry using the Chalkey count method. COX-2 expression and MVD data were correlated with each other and with other prognostic factors. Results: COX-2 expression, observed in 70 (79{\%}) cases, correlated positively with tumour type (p = 0.037) and tumour grade (p = 0.045), but negatively with oestrogen receptor (p = 0.013). It did not correlate with tumour size, axillary lymph node status, progesterone receptor and HER-2 status. MVD varied from 2.09 to 40.38, correlated positively with tumour grade (p = 0.050) and tumour size (p = 0.044), but negatively with progesterone receptor (p = 0.040). MVD did not correlate with tumour type, axillary lymph node status, oestrogen receptor and HER-2. There was no correlation between COX-2 expression and MVD (p = 0.702). Conclusions: COX-2 expression does not correlate with angiogenesis in breast cancer. Angiogenesis in breast cancer may be dependent on multiple genes, rather than on COX-2 alone.",
keywords = "Angiogenesis, Breast cancer, Cyclooxygenase, Immunohistochemistry, Microvessel density",
author = "Thorat, {Mangesh A.} and Sanjana Mehrotra and Akira Morimiya and Sunil Badve",
year = "2009",
month = "2",
day = "1",
doi = "10.1159/000178154",
language = "English (US)",
volume = "76",
pages = "39--44",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - COX-2 expression does not correlate with microvessel density in breast cancer

AU - Thorat, Mangesh A.

AU - Mehrotra, Sanjana

AU - Morimiya, Akira

AU - Badve, Sunil

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Background: Cyclooxygenase-2 (COX-2), implicated in carcinogenesis and tumour progression in many cancers including breast cancer, is hypothesised to cause progression by promoting angiogenesis. The exact mechanism of such action is not known and the clinical evidence of such interaction is weak. We studied COX-2 expression and microvessel density (MVD) in malignant breast tissues. Methods: COX-2 expression was analysed by immunohistochemistry in 89 breast cancer cases. MVD was assessed by CD31 immunohistochemistry using the Chalkey count method. COX-2 expression and MVD data were correlated with each other and with other prognostic factors. Results: COX-2 expression, observed in 70 (79%) cases, correlated positively with tumour type (p = 0.037) and tumour grade (p = 0.045), but negatively with oestrogen receptor (p = 0.013). It did not correlate with tumour size, axillary lymph node status, progesterone receptor and HER-2 status. MVD varied from 2.09 to 40.38, correlated positively with tumour grade (p = 0.050) and tumour size (p = 0.044), but negatively with progesterone receptor (p = 0.040). MVD did not correlate with tumour type, axillary lymph node status, oestrogen receptor and HER-2. There was no correlation between COX-2 expression and MVD (p = 0.702). Conclusions: COX-2 expression does not correlate with angiogenesis in breast cancer. Angiogenesis in breast cancer may be dependent on multiple genes, rather than on COX-2 alone.

AB - Background: Cyclooxygenase-2 (COX-2), implicated in carcinogenesis and tumour progression in many cancers including breast cancer, is hypothesised to cause progression by promoting angiogenesis. The exact mechanism of such action is not known and the clinical evidence of such interaction is weak. We studied COX-2 expression and microvessel density (MVD) in malignant breast tissues. Methods: COX-2 expression was analysed by immunohistochemistry in 89 breast cancer cases. MVD was assessed by CD31 immunohistochemistry using the Chalkey count method. COX-2 expression and MVD data were correlated with each other and with other prognostic factors. Results: COX-2 expression, observed in 70 (79%) cases, correlated positively with tumour type (p = 0.037) and tumour grade (p = 0.045), but negatively with oestrogen receptor (p = 0.013). It did not correlate with tumour size, axillary lymph node status, progesterone receptor and HER-2 status. MVD varied from 2.09 to 40.38, correlated positively with tumour grade (p = 0.050) and tumour size (p = 0.044), but negatively with progesterone receptor (p = 0.040). MVD did not correlate with tumour type, axillary lymph node status, oestrogen receptor and HER-2. There was no correlation between COX-2 expression and MVD (p = 0.702). Conclusions: COX-2 expression does not correlate with angiogenesis in breast cancer. Angiogenesis in breast cancer may be dependent on multiple genes, rather than on COX-2 alone.

KW - Angiogenesis

KW - Breast cancer

KW - Cyclooxygenase

KW - Immunohistochemistry

KW - Microvessel density

UR - http://www.scopus.com/inward/record.url?scp=59649118087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649118087&partnerID=8YFLogxK

U2 - 10.1159/000178154

DO - 10.1159/000178154

M3 - Article

C2 - 19188749

AN - SCOPUS:59649118087

VL - 76

SP - 39

EP - 44

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 1

ER -